Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Circ Cardiovasc Genet. 2011 Feb 15;4(2):179–187. doi: 10.1161/CIRCGENETICS.110.957662

Figure 2. Reduction in systolic blood pressure during dexmedetomidine.

Figure 2

The bar graphs depict the reduction in systolic BP from the last placebo infusion after each of three dexmedetomidine infusions, stratified by number of copies of haplotype 3 (upper panel) and haplotype 4 (or rs553668 minor alleles; lower panel). For statistical analysis, the single subject homozygous for HT3 was grouped with the heterozygous carriers. Error bars represent standard errors of the mean.